Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1

Status

Completed 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 4NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Urinary Bladder Neoplasms 1Carcinoma, Hepatocellular 1Bradycardia 1Arrhythmias, Cardiac 1Apnea 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1198Oxaliplatin 1160Capecitabine 1142Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × Atropine × Clear all
NCT07367178 2026-01-28

SATROPIN

MedSIR

Phase 2 Not yet recruiting
30 enrolled
Breast

Breast Neoplasms

NCT02839668 2019-10-29

TIVA/TCI-BC

Iuliu Hatieganu University of Medicine and Pharmacy

Phase 2 Completed
120 enrolled
Breast

Breast Neoplasms

NCT02228473 2014-10-28

Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort

Seoul National University Hospital

Phase NA Unknown
76 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00575523 2008-01-25

atropinePEI

Medical University of Vienna

Phase 4 Completed
31 enrolled
Gastrointestinal

Apnea, Arrhythmias, Cardiac, Bradycardia, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡